Retinopathy prevalence, incidence and trajectories in type 2 diabetes: The Fremantle diabetes study phase II.

Jocelyn J DrinkwaterTimothy M E DavisAngus W TurnerWendy A Davis

Published in: Diabetic medicine : a journal of the British Diabetic Association (2022)

The low incidence of at least moderate NPDR reflects the trajectory analysis. The currently recommended biennial retinal screening frequency for individuals without DR could potentially be extended.

Keyphrases

type diabetes
phase ii
risk factors
clinical trial
glycemic control
open label
cardiovascular disease
depressive symptoms
optical coherence tomography
diabetic retinopathy
high intensity
phase iii
randomized controlled trial
placebo controlled
double blind
optic nerve